Fredrik Piehl Selected Research

Fredrik Piehl Research Topics

Disease

77	Multiple Sclerosis 05/2024 - 06/2004
27	Relapsing-Remitting Multiple Sclerosis 05/2024 - 01/2015
16	Inflammation (Inflammations) 03/2024 - 10/2003
12	Psychotic Disorders (Schizoaffective Disorder) 01/2024 - 01/2018
11	Infections 05/2024 - 01/2012
10	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2024 - 01/2013
10	Schizophrenia (Dementia Praecox) 01/2024 - 01/2019
10	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 07/2009
9	Myasthenia Gravis 02/2024 - 03/2016
8	Disease Progression 12/2023 - 01/2013
7	Neuroinflammatory Diseases 03/2024 - 04/2013
5	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 10/2003
4	Fatigue 05/2024 - 03/2016
4	Neoplasms (Cancer) 03/2024 - 01/2015
4	COVID-19 12/2023 - 12/2021
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 05/2011
3	Thymoma (Thymic Carcinoma) 02/2024 - 11/2019
3	Nervous System Diseases (Neurological Disorders) 01/2024 - 01/2016
3	Alzheimer Disease (Alzheimer's Disease) 01/2024 - 01/2013
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 10/2023 - 01/2018
3	Cognitive Dysfunction 08/2023 - 11/2019
3	Normal Pressure Hydrocephalus 01/2021 - 09/2019
3	Encephalitis (Encephalitis, Rasmussen) 11/2017 - 08/2010
3	Rheumatoid Arthritis 01/2017 - 05/2005
2	Parkinson Disease (Parkinson's Disease) 01/2024 - 01/2020
2	Pain (Aches) 08/2023 - 03/2013
2	Wounds and Injuries (Trauma) 12/2021 - 05/2013
2	Autoimmune Diseases of the Nervous System 11/2021 - 03/2015
2	Progressive Multifocal Leukoencephalopathy 05/2021 - 06/2016
2	Brain Injuries (Brain Injury) 01/2021 - 09/2019
2	Atrophy 01/2021 - 01/2020
2	Systemic Lupus Erythematosus (Libman-Sacks Disease) 12/2020 - 02/2019
2	Demyelinating Diseases (Demyelinating Disease) 01/2020 - 01/2020
2	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2019 - 03/2015
2	Hypoxia (Hypoxemia) 01/2017 - 07/2002
2	Central Nervous System Diseases (CNS Diseases) 01/2015 - 02/2014
2	Herpes Simplex 01/2012 - 08/2010
1	Muscle Weakness 02/2024

Drug/Important Bio-Agent (IBA)

32	Biomarkers (Surrogate Marker)IBA 03/2024 - 01/2013
27	Rituximab (Mabthera)FDA Link 05/2024 - 02/2016
13	Proteins (Proteins, Gene)FDA Link 01/2024 - 04/2013
13	Natalizumab (Tysabri)FDA Link 11/2023 - 01/2011
10	Polytetrafluoroethylene (Teflon)FDA Link 01/2024 - 01/2019
8	Fingolimod Hydrochloride (FTY720)FDA Link 12/2023 - 06/2016
7	AutoantibodiesIBA 03/2024 - 06/2017
7	AntibodiesIBA 02/2024 - 02/2015
7	Dimethyl FumarateIBA 01/2022 - 02/2018
4	Complement System Proteins (Complement)IBA 01/2024 - 01/2013
4	Alemtuzumab (Campath)FDA Link 01/2022 - 01/2020
4	ocrelizumabIBA 01/2022 - 01/2018
4	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 11/2021 - 03/2015
4	CytokinesIBA 01/2019 - 05/2004
3	Glial Fibrillary Acidic ProteinIBA 03/2024 - 01/2023
3	Cholinergic ReceptorsIBA 02/2024 - 03/2016
3	Messenger RNA (mRNA)IBA 01/2024 - 06/2004
3	Blood Proteins (Serum Proteins)IBA 01/2023 - 10/2019
3	Glatiramer Acetate (Copaxone)FDA Link 01/2022 - 01/2018
3	insulin receptor-related receptor (IRR)IBA 10/2020 - 01/2015
3	Transcription Factors (Transcription Factor)IBA 01/2020 - 07/2002
3	MHC class II transactivator proteinIBA 07/2009 - 05/2005
2	Anti-Bacterial Agents (Antibiotics)IBA 05/2024 - 01/2016
2	TabletsIBA 12/2023 - 01/2022
2	Cladribine FDA LinkGeneric 12/2023 - 01/2022
2	teriflunomideIBA 08/2023 - 01/2022
2	Tumor Necrosis Factor Ligand Superfamily Member 14IBA 08/2023 - 11/2017
2	Lipocalin-2IBA 01/2023 - 02/2016
2	Dopamine (Intropin)FDA LinkGeneric 01/2023 - 01/2022
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2023 - 01/2013
2	Immunosuppressive Agents (Immunosuppressants)IBA 11/2022 - 01/2020
2	InterferonsIBA 01/2022 - 12/2020
2	Peptides (Polypeptides)IBA 01/2021 - 01/2017
2	AntioxidantsIBA 01/2021 - 01/2015
2	KynurenineIBA 01/2021 - 03/2020
2	NeurocanIBA 01/2021 - 09/2019
2	BrevicanIBA 01/2021 - 09/2019
2	Immunoglobulins (Immunoglobulin)IBA 10/2020 - 01/2019
2	Interferon-betaIBA 01/2020 - 01/2018
2	tocilizumab (atlizumab)FDA Link 11/2019 - 06/2017
2	Retinaldehyde (Retinal)IBA 11/2019 - 01/2017
2	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2019 - 10/2014
2	MicroRNAs (MicroRNA)IBA 01/2019 - 06/2016
2	ChemokinesIBA 01/2019 - 10/2003
2	CXC ChemokinesIBA 01/2019 - 01/2013
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2018 - 03/2013
2	HLA-DRB1 Chains (HLA DRB1)IBA 01/2018 - 01/2016
2	SphingolipidsIBA 01/2018 - 09/2015
2	ButyrylcholinesteraseIBA 01/2015 - 11/2013
2	C-Type Lectins (C-Type Lectin)IBA 12/2014 - 05/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2011 - 07/2002
2	Myelin-Oligodendrocyte GlycoproteinIBA 03/2008 - 10/2003

Therapy/Procedure

30	Therapeutics 05/2024 - 06/2016
4	Immunotherapy 05/2024 - 01/2020
4	Stem Cell Transplantation 09/2023 - 02/2015
3	Thymectomy 02/2024 - 11/2019
3	Activities of Daily Living (ADL) 11/2022 - 01/2019
2	Duration of Therapy 05/2024 - 11/2022
2	Off-Label Use 03/2024 - 01/2020
2	Critical Care (Surgical Intensive Care) 01/2022 - 02/2019
2	Hematopoietic Stem Cell Transplantation 01/2021 - 02/2015
2	Transplantation 01/2016 - 02/2015